Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
24/08/202115:05GlobeNewswire Inc.Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other EventsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
24/08/202106:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Tempol Significantly Inhibited Multiple Cytokines from COVID-19 Patient’s CellsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/08/202106:30GlobeNewswire Inc.Adamis Highlights National Institutes of Health (NIH) Article Entitled, “Tempol: A Potential Home Treatment for COVID-19”NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/08/202115:42Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/08/202116:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/08/202115:05GlobeNewswire Inc.Adamis Announces Agreement to Sell Portion of US Compounding BusinessNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/07/202115:05Business WireAdamis Announces Results of 2021 Annual Meeting of StockholdersNASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/07/202107:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/07/202107:00Business WireAdamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16thNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/07/202107:00Business Wire Adamis Sends Letter to Stockholders to Address Jerald A. Hammann’s Costly, Distracting and Misguided CampaignNASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/06/202106:00Business WireAdamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/06/202108:00Business WireAdamis Files Definitive Proxy Statement and Sends Letter to StockholdersNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/06/202105:03Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
11/06/202106:30GlobeNewswire Inc.Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/06/202106:30GlobeNewswire Inc.Adamis Provides Update on ZIMHI™NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/06/202106:30GlobeNewswire Inc.Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/06/202116:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/06/202107:20Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/06/202106:30GlobeNewswire Inc.Adamis Pharmaceuticals Provides Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/05/202115:04GlobeNewswire Inc.Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQNASDAQ:ADMPAdamis Pharmaceuticals Corporation
24/05/202116:22Edgar (US Regulatory)Amended Notification That Quarterly Report Will Be Submitted Late (nt 10-q/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/05/202115:05GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on First Quarter 2021 Financial Results Conference CallNASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/05/202106:30GlobeNewswire Inc.Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA for the Treatment of Opioid OverdoseNASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/05/202106:30GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2021 Financial Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/04/202115:51Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/04/202116:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/04/202115:39GlobeNewswire Inc.Adamis Pharmaceuticals Announces 2020 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/04/202115:03GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/04/202106:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides an Update on ZIMHI™NASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/03/202115:38Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP

Su Consulta Reciente

Delayed Upgrade Clock